Business Services Industry

Swedish pharmaceutical company Meda AB purchase product portfolio from Wyeth for SEK525m

Nordic Business Report, April 27, 2007

NORDIC BUSINESS REPORT-27 April 2007-Swedish pharmaceutical company Meda AB purchase product portfolio from Wyeth for SEK525m(C)1994-2007 M2 COMMUNICATIONS LTD http://www.m2.com

Swedish pharmaceutical company Meda AB said on Friday (27 April) that it has agreed to acquire a portfolio of 10 well-established pharmaceutical products from US group Wyeth.

The purchase price is approximately SEK525m.

The product portfolio will strengthen Meda's position on key European markets, especially Italy and France, and will boost sales for 2007 by SEK160-170m.

Then portfolio includes the anti-anxiety and tranquillising agents Seresta, Serpax, Serenal, Praxiten and Loramet, the cancer and MS drugs Novantrone, Elsep and Ralenova, and the sleep disorder products Sonata and Zerene.

Meda, headquartered in Solna, Sweden, is a speciality pharma company focusing on marketing and market-adapted product development. The company has 1,000 employees in 24 countries. Meda is listed on the Nordic Exchange in Stockholm.

One British pound (GBP) is worth approximately 13.55 Swedish kronor (SEK).

((Comments on this story may be sent to nbr.feedback@nordicbusinessreport.com))

COPYRIGHT 2007 M2 Communications Ltd.
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale